Valeant Pharmaceuticals sees third-quarter sales boost
September 29, 2014 at 19:53 PM EDT
Sept 29 (Reuters) - Valeant Pharmaceuticals International Inc, which is pursuing a hostile takeover offer for Allergan Inc, on Monday said it expects sales to rise 15 percent in the third quarter but will face a tougher fourth-quarter comparison to year-ago results.
